GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
110 hedge funds and large institutions have $214M invested in GenMark Diagnostics, Inc in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
26% less call options, than puts
Call options by funds: $682K | Put options by funds: $917K
Holders
110
Holding in Top 10
–
Calls
$682K
Puts
$917K
Top Buyers
| 1 | +$3.68M | |
| 2 | +$3.12M | |
| 3 | +$2.86M | |
| 4 |
NIM
Needham Investment Management
New York
|
+$2.67M |
| 5 |
EP
Eversept Partners
New York
|
+$2.16M |
Top Sellers
| 1 | -$8.36M | |
| 2 | -$4.7M | |
| 3 | -$3.59M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.89M |
| 5 |
Morgan Stanley
New York
|
-$2.32M |